More information on single agent obinituzumab AKA GA101 AKA Gazyva and CLL from ASCO 2014 on my blog: bkoffman.blogspot.com
I am posting all the audio interviews. The future looks bright. I have been working hard on a plan to build what needed to fill the yet unmet needs of the CLL community.
Stay strong. We are all in this together.